Page 11 - Harminder Kaur

Clinical trials show Wegovy 7.2 mg helps patients lose up to 21% body weight in 72 weeks. Learn how it compares to 2.4 mg and what to expect in the UK.

Wegovy 7.2 mg may help patients who’ve plateaued on lower doses. Learn who qualifies, when it’s coming to the UK, and how it fits into treatment plans.

Wegovy 7.2 mg is a higher-dose semaglutide for people who’ve reached a plateau on 2.4 mg. Learn who’s eligible, safety guidance, and UK approval status.

Discover how Mounjaro may support heart health beyond weight loss, with potential benefits for blood pressure, cholesterol, and cardiovascular wellbeing.

Discover signs you might be taking the wrong dose of sildenafil, possible side effects, and when to seek expert advice for safe use.

Thinking about restarting GLP-1 injections? Learn who may be eligible, dose adjustment needs, and what to expect when restarting GLP-1 treatment safely.

Learn how Mounjaro may affect your menstrual cycle. Understand possible period changes on GLP-1 medications and when to seek expert advice.

Embarking on a weight loss journey with Mounjaro, a promising medication in the realm of obesity management, is an exciting step toward achieving your health goals. But what role do dietary and lifestyle changes play alongside this innovative medication? In this blog, we'll explore the potential benefits of incorporating such changes into your routine while taking Mounjaro, also known as tirzepatide.

Menopause brings a whirlwind of change, and managing its symptoms, particularly hot flashes and night sweats, can feel like navigating a confusing maze. One common solution you'll encounter is hormone replacement therapy (HRT). But what if hormones aren't your cup of tea? Enter Veoza, a groundbreaking non-hormonal medication arriving in the UK market in January 2024. Now, the question arises: Veoza or HRT – which is the right choice for me?